Xeris Biopharma Holdings (XERS) Amortizatization of Intangibles (2021 - 2026)
Xeris Biopharma Holdings' Amortizatization of Intangibles was $2.71 million in Q2 2026, unchanged from $2.71 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Xeris Biopharma Holdings' Amortizatization of Intangibles was $10.84 million through Jun 30, 2026, unchanged year-over-year; for FY2025, it was $10.84 million, unchanged from FY2024.
- Amortizatization of Intangibles shows a four-year compound annual growth rate of 110.7% (FY2021 to FY2025).
- In earlier years, Amortizatization of Intangibles was $10.84 million in FY2024 (unchanged), $10.84 million in FY2023 (unchanged), $10.84 million in FY2022 and $550,000 in FY2021.
- The year-over-year growth in Amortizatization of Intangibles has ranged between 0.0% (Q1 2025) and 392.9% (Q4 2022) over the last five years.
- Per Business Quant data, XERS's Amortizatization of Intangibles in the three quarters before Q2 2026 was $2.71 million (Q1 2026), $2.71 million (Q4 2025) and $2.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 984.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 600.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Xeris Biopharma Holdings | 1.58 Bn | 1.14 Bn | 79.59 Mn | 2.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 2.71 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Sep 30, 2022 | 2.71 Mn |
| Jun 30, 2022 | 2.71 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 550,000.00 |
API Access
Xeris Biopharma Holdings Amortizatization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();